United
States Securities And Exchange Commission
Washington,
DC 20549
FORM
8-K
CURRENT
REPORT
Pursuant
to Section 13 or 15(d) of the Securities Exchange Act of 1934
Date of
Report (Date of Earliest Event Reported): December 7,
2009
(December
1, 2009)
ISORAY,
INC.
(Exact
name of registrant as specified in its charter)
Minnesota
|
|
001-33407
|
|
41-1458152
|
(State
or other jurisdiction
|
|
(Commission
|
|
(IRS
Employer
|
of
incorporation)
|
|
File
Number)
|
|
Identification
No.)
|
350 Hills Street, Suite 106,
Richland, Washington 99354
(Address
of principal executive offices) (Zip Code)
(509)
375-1202
(Registrant's
telephone number)
ITEM 1.01 Entry
into a Material Definitive Agreement
On
December 1, 2009, IsoRay Medical, Inc. ("Medical"), a wholly owned subsidiary of
IsoRay, Inc. (the "Registrant"), entered into a Contract (the "Agreement") with
UralDial LLC, a Russian company ("UralDial"). Under the Agreement,
Medical will purchase Cesium-131 from UralDial and UralDial will provide
Cesium-131 from at least two Russian facilities subject to scheduled maintenance
shutdowns of the facilities from time to time. The Agreement
stabilizes supply arrangements for the next 12 months beginning on December 1,
2009 and ending on December 31, 2010.
ITEM
9.01 Exhibits
|
10.56
|
Contract,
dated December 1, 2009, by and between IsoRay Medical, Inc. and UralDial
LLC (confidential treatment requested for redacted
portions)
|
SIGNATURES
In
accordance with the requirements of the Securities Exchange Act of 1934, the
Registrant has duly caused this report to be signed on its behalf by the
undersigned, hereunto duly authorized.
Dated: December
4, 2009
|
IsoRay,
Inc., a Minnesota corporation
|
|
|
|
By:
|
/s/ Dwight Babcock
|
|
|
|
Dwight Babcock, CEO
|
|